BRIEF published on 01/20/2026 at 15:58, 5 months 22 days ago Kopernik Global Investors crosses thresholds at EUROAPI Voting Rights Actions Crossing Thresholds EUROAPI Kopernik Global Investors
BRIEF published on 12/10/2025 at 17:50, 7 months 1 day ago Tristan Imbert Appointed as Independent Director at EUROAPI Pharmaceutical Industry Independent Director Audit Committee EUROAPI Tristan Imbert
PRESS RELEASE published on 12/10/2025 at 17:45, 7 months 1 day ago Tristan Imbert co-opted as Independent Director Tristan Imbert appointed Independent Director at EUROAPI, bringing expertise in pharmaceutical finance and strategy. Financial agenda includes FY 2025 results on 3 March 2026 and 2026 AGM on 27 May 2026 Financial Agenda Strategy EUROAPI Tristan Imbert Pharmaceutical Finance
BRIEF published on 09/18/2025 at 07:05, 9 months 23 days ago Science Based Targets initiative Validates EUROAPI's Climate Goals Sustainability GHG Emissions EUROAPI Climate Goals SBTi Validation
PRESS RELEASE published on 09/18/2025 at 07:00, 9 months 23 days ago Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets EUROAPI's near-term climate targets validated by the Science Based Targets initiative (SBTi) show significant reductions in greenhouse gas emissions, confirming alignment with the Paris Agreement Greenhouse Gas Emissions Science Based Targets Initiative Climate Targets Paris Agreement EUROAPI
BRIEF published on 06/30/2025 at 18:03, 1 year ago EUROAPI Divests Haverhill Site to Particle Dynamics Pharmaceutical EUROAPI FOCUS-27 Haverhill Sale Particle Dynamics
PRESS RELEASE published on 06/30/2025 at 17:58, 1 year ago EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan. Deal strengthens capabilities, market reach Acquisition EUROAPI FOCUS-27 Particle Dynamics Haverhill
BRIEF published on 06/19/2025 at 16:29, 1 year ago Goldman Sachs Crosses Thresholds in EUROAPI Voting Rights Actions Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 06/06/2025 at 16:03, 1 year 1 month ago EUROAPI General Assembly: Approval of Resolutions and Perspectives General Assembly EUROAPI Resolutions Approved R&D And CDMO Outlook 2023
BRIEF published on 06/04/2025 at 17:50, 1 year 1 month ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
Published on 07/11/2026 at 02:50, 1 day 4 hours ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 1 day 4 hours ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 1 day 4 hours ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 1 day 6 hours ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 04:00, 1 day 2 hours ago CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027
Published on 07/10/2026 at 18:40, 1 day 12 hours ago AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 1 day 13 hours ago WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 17:14, 1 day 13 hours ago Form 8.3 - SAFESTAY PLC: Opening Position Disclosure
Published on 07/10/2026 at 18:00, 1 day 12 hours ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 10:34, 1 day 20 hours ago Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 2 days 12 hours ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
